Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 2, Issue 9, Page 1 (September 2007)


View previous. 3 of 44 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (184 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

DOWNLOAD IMAGES

NEED REPRINTS?

FDA Approves Once-Yearly Bisphosphonate: Intravenous infusion takes 15 minutes.

ELIZABETH MECHCATIE (Senior Writer)

The intravenous bisphosphonate zoledronic acid has been approved as the first treatment for postmenopausal osteoporosis that is administered once a year.

PII: S1558-0164(07)70486-8

doi:10.1016/S1558-0164(07)70486-8


View previous. 3 of 44 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.